Plaster for treating hyperostosis

Abstract

The invention discloses a plaster for treating hyperostosis and relates to a plaster. The plaster is prepared from the following raw material medicines in percentage by weight: 1500-1760g of a hot melt adhesive, 40-60g of resina draconis, 35-60g of centipede, 55-70g of borneol, 30-40g of radix clematidis, 60-85g of dry red peppers, 45-50g of notopterygium roots, 80-90g of raw kusnezoff monkshood roots, 35-40g of divaricate saposhnikovia roots, 40-50g of semen brassicae, 70-80g of lumbricus, 60-70g of syzygium aromaticum, 25-35g of caulis spatholobi, 55-60g of zaocys dhumnade, 75-85g of rhizoma drynariae, 55-65g of rhizoma sparganii, 10-20ml of azone and 8-12g of nanophase ceramic powder. The plaster disclosed by the invention has the beneficial effects that the plaster for treating hyperostosis used has a stronger infiltration capacity by absorbing outside energies and heat energies of human body, can permeate skins and subcutaneous tissues, and has a resonance absorption effect with water molecules in human cells so as to have the effects of improving microcirculation and nutrition of tissue metabolism and promoting absorption of inflammatory exudates, and the plaster has the effects of activating blood to unblock the meridian, dispelling cold and relieving pains, softening hard masses and removing stasis, improving the blood circulation and promoting repair of damaged tissues as soon as possible.

Description

technical field [0001] The invention relates to a plaster, in particular to a plaster for treating hyperosteogeny. Background technique [0002] Osteoarthritis, also known as proliferative osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile arthritis, and hypertrophic arthritis, is due to the degeneration of soft tissues such as cartilage, intervertebral discs, and ligaments that make up the joints. Degeneration, the formation of bone spurs on the edge of the joint, hypertrophy of the synovium, and other changes, resulting in bone destruction, causing secondary bone hyperplasia, leading to joint deformation, and a disease that causes joint pain and limited mobility when subjected to abnormal loads . Traditional Chinese medicine believes that the disease is related to trauma, strain, blood stasis blocking collaterals, feeling wind-cold dampness, internal resistance of phlegm dampness, liver and kidney deficiency, etc. At present, oral medicine, intramusc...

AI Technical Summary

Problems solved by technology

At present, oral medicine, intramuscular injection or infusion is usually used for clinical treatment of bone hyperplasia. Oral medicine is more irritating to the gastrointestinal tract, which is unbearable for patients. Intramuscular injection and infusion will cause different degrees of damage to the liver and kidney. damage

Some existing plasters for the treatment of hyperosteogeny are not ideal for use, the main reasons are: the selection of raw materials is not accurate enough, the content of active ingredients in the plaster is low, and the permeability of the plaster is not good.

Images